藥物交互作用
Abatacept + Lisocabtagene maraleucel
嚴重程度: 嚴重
Abatacept and Lisocabtagene maraleucel: major interaction.
最後更新
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
摘要
Lisocabtagene maraleucel is a CAR T-cell product, and immunosuppressants such as abatacept may impair CAR T-cell expansion and activity. Both also add to infection risk in patients who are already immunocompromised.
用白話說明這項交互作用的意義
Abatacept and Lisocabtagene maraleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Abatacept belongs to Musculoskeletal; Lisocabtagene maraleucel belongs to Oncology.
為什麼會發生
Abatacept's T-cell costimulation blockade may suppress CAR T-cell function and adds to overall immunosuppression; the interaction is predicted from mechanism rather than established.
處置方式
Stop abatacept before leukapheresis and CAR T infusion where clinically possible, following the product labeling. Monitor closely for infection and for loss of CAR T efficacy if immunosuppression cannot be avoided.
可向藥師詢問的問題
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Abatacept 的其他交互作用
Lisocabtagene maraleucel 的其他交互作用
常見問題
Can I take Abatacept with Lisocabtagene maraleucel?
MediHelp rates the interaction as major. Abatacept and Lisocabtagene maraleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Lisocabtagene maraleucel is a CAR T-cell product, and immunosuppressants such as abatacept may impair CAR T-cell expansion and activity. Both also add to infection risk in patients who are already immunocompromised.
How serious is the interaction between Abatacept and Lisocabtagene maraleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop abatacept before leukapheresis and CAR T infusion where clinically possible, following the product labeling. Monitor closely for infection and for loss of CAR T efficacy if immunosuppression cannot be avoided.
What other medicines interact with Abatacept?
MediHelp also lists interactions of Abatacept with, for example, Adalimumab, Adenovirus types 4 and 7 live, Anakinra. The full list is on the Abatacept page.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
